About the reviewerView full bio Dr Colin Tidy, MRCGP General Practitioner, Medical Author MBBS, MRCGP, MRCP (Paediatrics), DCH Dr Colin Tidy is an NHS Doctor, based in Oxfordshire
The men who get lasting results from GLP-1 therapy are the ones who use the reduced appetite as a window to rebuild how they eat and how they live
10mg vial10mg/vial Research watchlist Get updates when availability, evidence, or category guidance changes for Dihexa
Community sources describe starting conservatively at 0.25 mg 3x weekly (0.75 mg total weekly) for the first 2-4 weeks the dual GLP-1/GIP mechanism can cause more intense initial GI side effects than single-target agonists
Health and wellness companies now have an opportunity to offer their customers a patented, science-backed product that addresses these challenges without compromising the effectiveness of their GLP-1 therapy. Relesium is launching in powder format, which can be used as a standalone supplement or within other product formulations starting January 2025